María‐Jesús Pinazo

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 292 citations · Full text

Pharmacology, Gastroenterology, Placebo-controlled Trial +2

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

Faustino Torrico, Joaquím Gascón, Fabiana Barreira et al. · The Lancet Infectious Diseases · 2021 · 194 citations · Full text

Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults

María‐Jesús Pinazo, José Muñóz, Elizabeth Posada et al. · Antimicrobial Agents and Chemotherapy · 2010 · 186 citations · Full text

Benznidazole-Related Adverse Drug Reactions and Their Relationship to Serum Drug Concentrations in Patients with Chronic Chagas Disease

María‐Jesús Pinazo, Laura Guerrero, Elizabeth Posada et al. · Antimicrobial Agents and Chemotherapy · 2012 · 141 citations · Full text

Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus Erythematosus

María‐Jesús Pinazo, Gerard Espinosa, Montserrat Gállego et al. · American Journal of Tropical Medicine and Hygiene · 2010 · 131 citations · Full text

Successful Treatment, Immunology, American Trypanosomiasis +17